Metformin for treatment of cytopenias in children and young adults with Fanconi anemia.

Autor: Pollard JA; Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA., Furutani E; Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA., Liu S; Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Harvard Medical School, Boston, MA., Esrick E; Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA., Cohen LE; Department of Pediatrics, Harvard Medical School, Boston, MA.; Department of Endocrinology, and., Bledsoe J; Department of Pathology, Boston Children's Hospital, Boston, MA., Liu CW; Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC., Lu K; Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC., de Haro MJR; Joint Research Unit UAB-Sant Pau Biomedical Research Institute,Institut de Recerca Hospital de la Santa Creu i Sant Pau-IIB Sant Pau, Universitat Autònoma de Barcelona, Barcelona Spain.; Center for Biomedical Network Research on Rare Diseases, Madrid, Spain., Surrallés J; Joint Research Unit UAB-Sant Pau Biomedical Research Institute,Institut de Recerca Hospital de la Santa Creu i Sant Pau-IIB Sant Pau, Universitat Autònoma de Barcelona, Barcelona Spain.; Center for Biomedical Network Research on Rare Diseases, Madrid, Spain., Malsch M; Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Clinical Research Operations Center, Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA., Kuniholm A; Clinical Research Operations Center, Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA., Galvin A; Clinical Research Operations Center, Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA., Armant M; Trans Laboratory, Boston Children's Hospital, Boston, MA., Kim AS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Ballotti K; Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Moreau L; Comprehensive Center for Fanconi Anemia, Dana-Farber Cancer Institute, Boston, MA., Zhou Y; Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA., Babushok D; Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA., Boulad F; Pediatric Hematology-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY., Carroll C; Pediatric Hematology-Oncology, The Children's Hospital at TriStar Centennial, Nashville, TN., Hartung H; Pediatric Hematology-Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Hont A; Pediatric Hematology-Oncology, Children's National Medical Center, Washington, DC., Nakano T; Pediatric Hematology-Oncology, Children's Hospital Colorado, Denver, CO., Olson T; Pediatric Hematology-Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Sze SG; Department of Pediatrics, Maine Medical Center, Tufts University School of Medicine, Portland, ME., Thompson AA; Pediatric Hematology-Oncology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Wlodarski MW; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN., Gu X; Beth Israel Deaconess Medical Center Genomics, Proteomics, Bioinformatics and Systems Biology Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Libermann TA; Beth Israel Deaconess Medical Center Genomics, Proteomics, Bioinformatics and Systems Biology Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., D'Andrea A; Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Grompe M; Oregon Stem Cell Center, Department of Pediatrics, Papé Family Institute, Oregon Health and Science University, Portland, OR; and., Weller E; Department of Pediatrics, Harvard Medical School, Boston, MA.; Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Harvard Medical School, Boston, MA., Shimamura A; Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA.

Publikováno v: Blood advances [Blood Adv] 2022 Jun 28; Vol. 6 (12), pp. 3803-3811.